Praxis Precision Medicines Inc. (United States) is listed on the Nasdaq and has a market capitalization of $9.25 billion, with shareholders equity totaling $1.26 billion.
The company employs approximately 51 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Praxis Precision Medicines Inc. reported $- in revenue, generating net income of $-359.43 million.
Key financial metrics include a P/E ratio of -25.74, a price-to-book (P/B) ratio of 7.34, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker PRAX.